Wrocław, Poland
3 - 7 May 2014

Satellite Symposia

SATURDAY 3 MAY

  • 15:00 – 17:00 Sandoz Biopharmaceuticals Satellite Symposium: Imaging in Endocrinology: latest insights and future development

SUNDAY 4 MAY

  • 18:30 – 20:00 Ipsen Satellite Symposium: Somatostatin analogues in acromegaly & NETs: an evolving story from science to everyday clinical practice
  • 18:30 – 20:00 Genzyme Satellite Symposium: Challenges in thyroid cancer management
  • 18:30 – 20:00 NovoNordisk Satellite Symposium: Insulin in historical perspective

MONDAY 5 MAY

  • 07:00 - 08:30 Pfizer Meet the Expert: Clinical management in acromegaly: A Meet the Expert session
  • 18:30 – 20:00 Novartis Pharmaceuticals Satellite Symposium: Exploring the management of pituitary tumours: an expert discussion

  • 18:30 – 20:00 Pfizer Satellite Symposium: A spotlight on acromegaly: an interactive session

  • 18:30 – 20:00 ViroPharma Satellite Symposium: Insights into the management of adrenal insufficiency

TUESDAY 6 MAY

  • 07:00 – 08:30 Rare Disease Satellite Symposium - Alexion, Viropharma and Bioscientifica: Changing landscapes in the treatment of rare disease

WEDNESDAY 7 MAY

  • 07:00 – 08:30 IDS Satellite Symposium: Primary aldosteronism in Endocrine Hypertension: Screening and confirmatory testing using the automated IDS-iSYS Aldosterone and Direct Renin

Please see below for further information

 

SATURDAY 3 MAY

15:00 – 17:00 Sandoz Biopharmaceuticals Satellite Symposium

Imaging in Endocrinology: latest insights and future development

Chairs: G Stalla (Germany) & S Webb (Spain)

AUDITORIUM

15:00 Introduction from the chairs

15:10 Pituitary imaging  JF Bonneville (Belgium)

15:35 Multimodal imaging of the parathyroid glands in primary hyperparathyroidism R Prommegger (Austria)

16:00 Imaging in pheochromocytoma G Karanikas (Austria)

16:25 The use of functional MRI to study appetite control in CNS W Dhillo (UK)

16:50 Questions and answers

 

SUNDAY 4 MAY

18:30 – 20:00 Ipsen Satellite Symposium

Somatostatin analogues in acromegaly & NETs: an evolving story from science to everyday clinical practice

Chair: B Kos-Kudla (Poland)

AUDITORIUM

18:30 Welcome B Kos-Kudla (Poland)

18:35 The changing landscape of somatostatin receptors J Castaño (Spain)

18:50 SSAs and acromegaly: managing well-controlled patients by extending the duration of biochemical control    S Neggers (The Netherlands)

19:15 SSAs and NETs: controlling symptoms and tumour progression M Pavel (Germany)

19:40 Role of SSA therapy in MEN1 management: clinical cases P Newey (UK)

19:55 Chair’s conclusions B Kos-Kudla (Poland)

 

18:30 – 20:00 Genzyme Satellite Symposium

Challenges in thyroid cancer management

Chair: G Kaminski (Poland)

CONFERENCE ROOMS A&B

18:30 Fine needle aspiration biopsy – an alternative to surgical approach in thyroid nodules? D Führer (Germany)

19:00 New trends in thyroid cancer ablative treatment M Melo (Portugal)

19:30 Implications of risk re-stratification on the follow-up of thyroid cancer patients R Elisei (Italy)

 

18:30 – 20:00 NovoNordisk Satellite Symposium

Insulin in historical perspective

Chairs: M Nattrass (UK) & J Sandahl Christiansen (Denmark)

MULTI ROOM

18:30 Welcome and introduction

Chairs: M Nattrass (UK) & J Sandahl Christiansen (Denmark)

18:35 The discovery of insulin B Zinman (Canada)

18:55 Insulin – a treatment, but not a cure. The need to refine insulin therapy J Sandahl Christiansen (Denmark)

19:05 Absorption and predictability T Heise (Germany)

19:20 Hypoglycaemia in historical perspective S Heller (UK)

19:35 A look into the future E Nishimura (Denmark)

19:50 Question and answer session

 

MONDAY 5 MAY

07:00 - 08:30 Pfizer Meet the Expert

Clinical management in acromegaly: A Meet the Expert session

IMPERIAL HALL - CENTENNIAL HALL

The management of acromegaly patients can be challenging - as well as the endocrine consequences of the disease, there are also the comorbidities to consider. We invite you to our interactive Meet the Expert session to hear how an expert in the field manages his patients. Philippe Chanson, Professor of Endocrinology, Le Kremlin Bicetre, Paris, will discuss patient management through interactive case studies, with an opportunity for you to participate.

Participation is by invitation only.

 

18:30 – 20:00 Novartis Pharmaceuticals Satellite Symposium

Exploring the management of pituitary tumours: an expert discussion

Chair: M Reincke (Germany)

AUDITORIUM

18:30 Welcome and introduction M Reincke (Germany)

18:35 The complexities of managing Cushing’s disease

Presenter: R Feelders (The Netherlands)

Discussants: M Reincke (Germany) & M Gadelha (Brazil)

19:15 The importance of treating to biochemical targets in acromegaly

Presenter: D Ferone (Italy)

Discussants: M Reincke (Germany) & M Gadelha (Brazil)

19:55 Concluding remarks M Reincke (Germany)

 

18:30 – 20:00 Pfizer Satellite Symposium

A spotlight on acromegaly: an interactive session

Host: F Casanueva (Spain)

MULTI ROOM

Panel Members: M Buchfelder (Germany), C Strasburger (Germany), AJ Van der Lely (The Netherlands)

Our distinguished faculty will share their knowledge and expertise in a forum designed to highlight topical issues surrounding diagnosis and treatment of acromegaly, including:

• The history of acromegaly

• Neuro-anatomy, neurosurgery and sellar abnormalities

• Role of medical therapies in the treatment paradigm

• ACROSTUDY: the implications for clinical practice

 

18:30 – 20:00 ViroPharma Satellite Symposium

Insights into the management of adrenal insufficiency

Chair: E Ghigo (Italy)

CONFERENCE ROOMS A&B

18.30 Welcome and introductions E Ghigo (Italy)

18.35 Adrenal insufficiency today A Grossman (UK)

18.55 The cortisol circadian rhythm revisited: how current understanding can inform our clinical practice E van Cauter (Belgium)

19.15 Improving glucocorticoid replacement therapy G Johannsson (Sweden)

19.35 Patient cases and physician experience G Meyer (Germany)

19.55 Summary and close E Ghigo (Italy)

 

TUESDAY 6 MAY

07:00 – 08:30 Rare Disease Satellite Symposium - Alexion, Viropharma and Bioscientifica

Changing landscapes in the treatment of rare disease

Chair: P Trainer (UK)

CONFERENCE ROOMS A&B

07:00 - 07:05 Chairman’s introduction P Trainer (UK)

07:05 - 07:25 Rare diseases - what are they? What’s in a label? P Trainer (UK)

07:25 - 07:50 The orphan disease environment driving therapy innovation in patients with adrenal insufficiency     G Johannsson (Sweden)

07:50 - 08:15 Introducing Hypophosphatasia (HPP): a rare, inherited metabolic disease with wide-spectrum clinical presentation A Linglart (France)

08:15 - 08:30 Panel discussion and Chairman’s concluding comments

 

WEDNESDAY 7 MAY

07:00 – 08:30 IDS Satellite Symposium

Primary aldosteronism in Endocrine Hypertension: Screening and confirmatory testing using the automated IDS-iSYS Aldosterone and Direct Renin

Chairs: A Morganti (Italy) & R Cifkova (Czech Republic)

CONFERENCE ROOMS C&D

07:00 Primary hyperaldosteronism: Clinical features and diagnostic algoithm A Morganti (Italy)

07:30 Laboratory diagnostic considerations on screening using the ARR, the saline infusion test, and differential diagnosis of PA M Bidlingmaier (Germany)

08:00 Epidemiological data on the prevalence of primary hyperaldosteronism in the Czech Republic                        R Cifkova (Czech Republic)